What's New Related to Drugs
Updated Monday through Friday:
September 25, 2020
- FDA Drug Shortages
- Cisatracurium Besylate Injection (Updated - Currently in Shortage)
- Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)
- Etomidate Injection (Updated - Currently in Shortage)
- Furosemide Injection, USP (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
- Ropivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Vecuronium Bromide for Injection (Updated - Currently in Shortage)
Recent New and Generic Drug Approvals
This report displays final approvals and tentative approvals of original and supplemental applications for the two days beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this time span. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.
September 25, 2020
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Zocor NDA #019766 | Simvastatin | Tablet; Oral | SUPPL-101 | Msd Merck Co | Labeling | Approved |
Pravachol NDA #019898 | Pravastatin Sodium | Tablet; Oral | SUPPL-69 | Bristol Myers Squibb | Labeling | Approved |
Lipitor NDA #020702 | Atorvastatin Calcium | Tablet; Oral | SUPPL-78 | Upjohn | Labeling | Approved |
Lescol Xl NDA #021192 | Fluvastatin Sodium | Tablet, Extended Release; Oral | SUPPL-31 | Novartis | Labeling | Approved |
Altoprev NDA #021316 | Lovastatin | Tablet, Extended Release; Oral | SUPPL-36 | Covis Pharma Bv | Labeling | Approved |
Crestor NDA #021366 | Rosuvastatin Calcium | Tablet; Oral | SUPPL-42 | Ipr | Labeling | Approved |
Vytorin NDA #021687 | Ezetimibe; Simvastatin | Tablet; Oral | SUPPL-63 | Msd Intl | Labeling | Approved |
Livalo NDA #022363 | Pitavastatin Calcium | Tablet; Oral | SUPPL-18 | Kowa Co | Labeling | Approved |
Nucala BLA #125526 | Mepolizumab | Injectable; Subcutaneous Lyophilized Power | SUPPL-17 | Glaxosmithkline Llc | Efficacy | Approved |
Liptruzet NDA #200153 | Atorvastatin Calcium; Ezetimibe | Tablet; Oral | SUPPL-12 | Merck Sharp Dohme | Labeling | Approved |
Flolipid NDA #206679 | Simvastatin | Suspension; Oral | SUPPL-3 | Tcg Fluent Pharma | Labeling | Approved |
Zypitamag NDA #208379 | Pitavastatin Magnesium | Tablet; Oral | SUPPL-4 | Medicure | Labeling | Approved |
Ezallor Sprinkle NDA #208647 | Rosuvastatin Calcium | Capsule; Oral | SUPPL-4 | Sun Pharma Global | Labeling | Approved |
Ezallor Sprinkle NDA #208647 | Rosuvastatin Calcium | Capsule; Oral | SUPPL-4 | Sun Pharma Global | Labeling | Approved |
Nikita NDA #209875 | Pitavastatin Sodium | Tablet; Oral | SUPPL-2 | Lupin Ltd | Labeling | Approved |
Nucala BLA #761122 | Mepolizumab | Injectable; Subcutaneous | SUPPL-5 | Glaxosmithkline | Labeling | Approved |
September 24, 2020
Drug Name and Application Number | Active Ingredient | Dosage Form/ Route | Submission | Company | Submission Classification | Submission Status |
---|---|---|---|---|---|---|
Arthrotec NDA #020607 | Diclofenac Sodium; Misoprostol | Tablet, Delayed Release; Oral | SUPPL-36 | Pfizer | Labeling | Approved |
Arthrotec NDA #020607 | Diclofenac Sodium; Misoprostol | Tablet, Delayed Release; Oral | SUPPL-36 | Pfizer | Labeling | Approved |
Arthrotec NDA #020607 | Diclofenac Sodium; Misoprostol | Tablet, Delayed Release; Oral | SUPPL-36 | Pfizer | Labeling | Approved |
Implanon NDA #021529 | Etonogestrel | Implant; Implantation | SUPPL-19 | Organon Usa Inc | Labeling | Approved |
Implanon NDA #021529 | Etonogestrel | Implant; Implantation | SUPPL-20 | Organon Usa Inc | Labeling | Approved |
Implanon NDA #021529 | Etonogestrel | Implant; Implantation | SUPPL-19 | Organon Usa Inc | Labeling | Approved |
Nexplanon NDA #021529 | Etonogestrel | Implant; Implantation | SUPPL-19 | Organon Usa Inc | Labeling | Approved |
Nexplanon NDA #021529 | Etonogestrel | Implant; Implantation | SUPPL-20 | Organon Usa Inc | Labeling | Approved |
Nexplanon NDA #021529 | Etonogestrel | Implant; Implantation | SUPPL-19 | Organon Usa Inc | Labeling | Approved |
Reyataz NDA #021567 | Atazanavir Sulfate | Capsule; Oral | SUPPL-44 | Bristol Myers Squibb | Labeling | Approved |
Reyataz NDA #021567 | Atazanavir Sulfate | Capsule; Oral | SUPPL-44 | Bristol Myers Squibb | Labeling | Approved |
Revlimid NDA #021880 | Lenalidomide | Capsule; Oral | SUPPL-54 | Celgene | REMS | Approved |
Benlysta BLA #125370 | Belimumab | Injectable; Injection | SUPPL-71 | Human Genome Sciences Inc. | Efficacy | Approved |
Stivarga NDA #203085 | Regorafenib | Tablet; Oral | SUPPL-12 | Bayer Hlthcare | Labeling | Approved |
Kalydeco NDA #203188 | Ivacaftor | Tablet; Oral | SUPPL-33 | Vertex Pharms | Efficacy | Approved |
Reyataz NDA #206352 | Atazanavir Sulfate | Powder; Oral | SUPPL-8 | Bristol Myers Squibb | Labeling | Approved |
Reyataz NDA #206352 | Atazanavir Sulfate | Powder; Oral | SUPPL-8 | Bristol Myers Squibb | Labeling | Approved |
Kalydeco NDA #207925 | Ivacaftor | Granule; Oral | SUPPL-11 | Vertex Pharms Inc | Efficacy | Approved |
Alaway ANDA #208158 | Ketotifen Fumarate | Solution/Drops; Ophthalmic | ORIG-1 | Bausch | Approved | |
Dimethyl Fumarate ANDA #210305 | Dimethyl Fumarate | Capsule, Delayed Release; Oral | ORIG-1 | Cipla | Approved | |
Dimethyl Fumarate ANDA #210402 | Dimethyl Fumarate | Capsule, Delayed Release; Oral | ORIG-1 | Amneal | Approved | |
Dimethyl Fumarate ANDA #210440 | Dimethyl Fumarate | Capsule, Delayed Release; Oral | ORIG-1 | Alkem Labs Ltd | Approved | |
Dimethyl Fumarate ANDA #210460 | Dimethyl Fumarate | Capsule, Delayed Release; Oral | ORIG-1 | Msn | Approved | |
Dimethyl Fumarate ANDA #210499 | Dimethyl Fumarate | Capsule, Delayed Release; Oral | ORIG-1 | Accord Hlthcare | Approved | |
Dimethyl Fumarate ANDA #210500 | Dimethyl Fumarate | Capsule, Delayed Release; Oral | ORIG-1 | Hetero Labs Ltd Iii | Approved | |
Dimethyl Fumarate ANDA #210538 | Dimethyl Fumarate | Capsule, Delayed Release; Oral | ORIG-1 | Zydus Pharms | Approved | |
Naproxen Sodium and Diphenhydramine Hydrochloride ANDA #213663 | Diphenhydramine Hydrochloride; Naproxen Sodium | Tablet; Oral | ORIG-1 | Granules India Ltd | Approved | |
Cyanocobalamin ANDA #214390 | Cyanocobalamin | Injectable; Injection | ORIG-1 | Gland Pharma Ltd | Approved |
No hay comentarios:
Publicar un comentario